skip to main content

Matt Maurer speaks to The Globe and Mail regarding the ongoing situation at CannTrust

Shares of CannTrust Holdings Inc. dropped 22 per cent on Wednesday, a day after The Globe and Mail reported both CannTrust’s chairman and chief executive officer were informed about cannabis being grown in parts of a facility that had not been licensed seven months before Health Canada uncovered the regulatory breach.

Matt Maurer, the vice-chairman of Toronto-based Torkin Manes LLP’s Cannabis Law Group, said he’s received a large number of calls from U.S. financial institutions over the past several days inquiring about the situation at CannTrust.

“It seems like these calls are more like, ‘should we be selling and should we be shorting?’ versus, ‘where should we be looking to buy at the low end?’ ” Mr. Maurer said, referring to the practice of short-selling, where investors bet on share price declines.

This article was originally published on The Globe and Mail website. To read the complete article, visit The Globe and Mail

Most Recent Posts

Manitoba Announces Expansion of Cannabis Retail Market

Manitoba has announced that it will again be opening up and expanding its cannabis retail store licensing in the Province. This is the first opportuni...
May 27, 2020

Matt Maurer speaks to Grow Opportunity about Health Canada's policy change

Matt Maurer speaks to Grow Opportunity about Health Canada's policy change.
May 20, 2020

Nova Scotia Court of Appeal Decision a Big Interim Win for Organigram

Last week the Nova Scotia Court of Appeal partially overturned the certification of a class action lawsuit against Organigram Inc. and its parent comp...
May 5, 2020